Medical breakthrough starts with eye tests
The first human trial of the cell reprogramming technology for aging entered a new phase, as Life Biosciences in Boston began testing a treatment based on Yamanaka factors, a set of proteins believed to potentially promote cell regeneration and enhance healthy aging.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)